Patents by Inventor Saskia TRUMP

Saskia TRUMP has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • INTERLEUKIN-4-INDUCED GENE 1 (IL4I1) AND RESPECTIVE METABOLITES AS BIOMARKERS FOR CANCER
    Publication number: 20230032216
    Abstract: The present invention relates to the use of Interleukin-4-induced gene 1 (IL4I1) as well as metabolites as produced by IL4I1 as marker in diagnosis and therapy of cancer and related metastasis and/or resistance to immunotherapy.
    Type: Application
    Filed: December 10, 2020
    Publication date: February 2, 2023
    Applicant: Deutsches Krebsforschungszentrum Stiftung des oeffentlichen Rechts Im Neuenheimer Feld 280
    Inventors: Alexander Boehme, Saskia Trump, Luis Felipe Somarribas Patterson, Ahmed Sadik, Christiane A. Opitz
  • ARYL HYDROCARBON RECEPTOR (AHR) ACTIVATION SIGNATURE AND METHODS FOR DETERMINING AHR SIGNALING STATUS
    Publication number: 20220195533
    Abstract: The present disclosure relates to the generation and uses of an improved set of biomarkers that are aryl hydrocarbon receptor (AHR) target genes, designated as “AHR biomarkers.” The AHR biomarkers described herein allow one to efficiently determine AHR activation groups and sub-groups, in particular for an improved classification of tumors. As used herein, AHR activation groups are called “AHR activation signatures”. The AHR biomarkers comprise markers that are important in diagnosis and therapy, for example for selecting patients for treatment with AHR activation modulating interventions, and monitoring of therapy response.
    Type: Application
    Filed: March 28, 2020
    Publication date: June 23, 2022
    Applicant: DEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES OFFENTLICHEN RECHTS
    Inventors: Christiane A. OPITZ, Ahmed SADIK, Saskia TRUMP, Soumya R. MOHAPATRA, Sascha SCHÄUBLE, Erik FÄSSLER, Luis F. SOMARRIBAS PATTERSON
  • INTERLEUKIN-4-INDUCED GENE 1 (IL4I1) AS A BIOMARKER AND USES THEREOF
    Publication number: 20220170096
    Abstract: The present invention relates to a newly identified AHR-activating enzyme and uses thereof as marker in the diagnosis and therapy, for example for selecting patients for treatment with IL4I1-modulating interventions, and monitoring of therapy response.
    Type: Application
    Filed: April 9, 2020
    Publication date: June 2, 2022
    Applicants: DEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES OEFFENTLICHEN RECHTS, HELMHOLTZ-ZENTRUM FUER UMWELTFORSCHUNG GMBH ? UFZ
    Inventors: Christiane A. OPITZ, Ahmed SADIK, Luis Felipe SOMARRIBAS PATTERSON, Soumya R. MOHAPATRA, Mirja Tamara PRENTZELL, Philipp SECKER, Saskia TRUMP